×
Hero Background

Balantidiasis Companies

ID: MRFR/Pharma/3303-HCR
200 Pages
Rahul Gotadki
October 2025

Balantidiasis companies specialize in providing medical solutions for individuals affected by balantidiasis, a parasitic infection caused by the protozoan Balantidium coli. These companies contribute to infectious disease management by developing antiparasitic medications, supportive care options, and preventive measures for balantidiasis.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Balantidiasis Market Research Report- Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Balantidiasis Market

Balantidiasis Key Companies

 

Latest Balantidiasis Companies Update


Jan 2024Pfizer Conducted research on the efficacy and safety of their broad-spectrum antibiotic, Albendazole, for treating Balantidiasis.Partnered with research institutions in endemic regions to improve diagnosis and treatment protocols for balantidiasis.


Abbott Laboratories Collaborated with the CDC on a project to develop rapid diagnostic tests for balantidiasis, aiming for faster and more accurate diagnosis in resource-limited settings.Invested in research on alternative treatment options for balantidiasis, exploring the potential of herbal remedies and natural compounds.


World Health Organization (WHO) Updated their guidelines on the management of balantidiasis, emphasizing early diagnosis, effective treatment, and preventive measures like improved sanitation and hygiene practices.Provided technical assistance to countries with high balantidiasis burden to strengthen their healthcare systems and implement control strategies.


List of Balantidiasis Key Companies in the Market



  • Pfizer (U.S.)

  • Abbott (U.S.)

  • GlaxoSmithKline plc. (U.K)

  • BD (U.S.)

  • Sandoz International GmbH (Germany)

  • Amneal Pharmaceuticals LLC. (U.S.)

  • Akorn, Inc. (U.S.)

  • PharmaDerm, a division of Fougera Pharmaceuticals Inc. (U.S.)